SNUBI Research ::   (277 talks satisfying Presenter = )
All  Seminar  BioEMR  xMutant  SysBiol  MAInfo  J.Club  TopicSem  BookReading    This week    Help

ADD NEW USER

:   ǥ:    /Ű:    ¥:   

2020-08:
24   TopicSem

2020-07:
11 De novo variants in exomes of congenital heart disease patients identify risk genes and pathways     J.Club
23   TopicSem

2020-06:
25 WES analysis of 25 patients with post ERCP pancreatitis  TopicSem

2020-05:
09 Blacklisting variants common in private cohorts but not in public databases optimizes human exome analysis     J.Club
18 Tables and figures of AAP data analysis results using the modified workflow  xMutant
21 Retrieval of AAP patients with acute pancreatitis caused by drugs in UK Biobank data  MAInfo
25 Whole exome sequencing analysis of asparaginase-associated pancreatitis in Korean pediatric patients  TopicSem

2020-04:
02 Modified figures and tables of WES analysis of AAP in Korean pediatric patients  TopicSem
02 Modified figures and tables of WES analysis of AAP in Korean pediatric patients  TopicSem
06 Candidate variants list by differential cut-off in Asparaginase associated pancreatitis   xMutant
27 WES Analysis to search the risk factor of anthracycline-induced prolonged neutropenia  TopicSem

2020-03:
05 Figures and tables of WES analysis of AAP in Korean pediatric patients  TopicSem
07 Time to Rethink the Genetic Architecture of Long QT Syndrome      J.Club
19 Figures and tables of WES analysis of AAP in Korean pediatric patients   MAInfo

2020-02:
27 Study overview of post ERCP pancreatitis  xMutant

2020-01:
02 WES Analysis to search the risk factor of anthracycline-induced prolonged neutropenia  TopicSem
02 WES Analysis to search the risk factor of anthracycline-induced prolonged neutropenia  TopicSem
02 Therapeutic index measured on FDA approved drugs for population comparison  xMutant
16 WES Analysis to search the risk factor of anthracycline-induced prolonged neutropenia  MAInfo
23 WES Analysis to search the risk factor of anthracycline-induced prolonged neutropenia   TopicSem

2019-12:
19 WES Analysis to search the risk factor of anthracycline-induced prolonged neutropenia  TopicSem
28 Determining the balance between drug efficacy and safety by the network and biological system profile of its therapeutic target     J.Club

2019-11:
14 WES Analysis to search the risk factor of anthracycline-induced prolonged neutropenia  TopicSem
14 A coding variant in FTO related to thiopurine-induced leukopenia in East Asian  xMutant

2019-10:
10 Characteristic of pathogenic genes in ALL childhood patients with adverse reaction in L-asparaginase  TopicSem
10 WES analysis of AML samples according to neutropenia duration   MAInfo
19 Genotype-based Treatment With Thiopurine Reduces Incidence of Myelosuppression in Patients With Inflammatory Bowel Diseases     J.Club
21 Genomic analysis of L-asparaginase-induced pancreatitis in 25 Korean pediatric ALL patients.  Seminar
26 Genotype-based Treatment With Thiopurine Reduces Incidence of Myelosuppression in Patients With Inflammatory Bowel Diseases      J.Club

2019-09:
19 Analysis of genetic and clinical data in AML patients with prolonged neutropenia   xMutant

2019-08:
03 Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation     J.Club
29 Characteristic of pathogenic genes in ALL childhood patients with adverse effect in L-asparaginase  TopicSem

2019-07:
11 WES Analysis using multiple samples with side effects of L-asparaginase  TopicSem
11 Candidate variants of regression analysis in AML patients with prolonged neutropenia  xMutant
11 MetaDome: Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains  MAInfo

2019-06:
10 Analysis of candidate variants in patients with side effects of L-asparaginase  TopicSem

2019-05:
16 The Medical Genome Reference Bank: a whole-genome data resource of 4000 healthy elderly individuals. Rationale and cohort design  xMutant
16 Case-control analysis identifies shared properties of rare germline variation in cancer predisposing genes   MAInfo
25 Interpreting the clinical significance of combined variants in multiple recessive disease genes: systematic investigation of Joubert syndrome yields little support for oligogenicity.     J.Club

2019-04:
29 Analysis of candidate variants in patients with side effects of L-asparaginase  TopicSem

2019-03:
16 Rapid and accurate interpretation of clinical exomes using Phenoxome: a computational phenotype-driven approach     J.Club
25 Analysis of candidate variants in patients with side effects of L-asparaginase  TopicSem
28 Settling the score  MAInfo

2019-02:
11 Analysis of candidate variants in patients with side effects of L-asparaginase  TopicSem

2019-01:
03 Analysis of candidate variants in patients with side effects of L-asparaginase  TopicSem
10 Analysis of candidate variants in patients with side effects of L-asparaginase  MAInfo
12 High Yield of Pathogenic Germline Mutations Causative or Likely Causative of the Cancer Phenotype in Selected Children with Cancer     J.Club
22 WES analysis of AML samples according to neutropenia duration   xMutant

2018-12:
26 L-asparaginase induced acute pancreatitis in pediatric ALL patients  Seminar

2018-11:
20 WES analysis of AML samples according to neutropenia duration   xMutant
29 L-asparaginase induced acute pancreatitis in 26 pediatric ALL patients  TopicSem

2018-06:
12 WES analysis of AML samples according to neutropenia duration   xMutant
14 L-asparaginase associated acute pancreatitis in pediatric ALL patients  TopicSem

2018-05:
07 WES analysis of AML samples according to prolonged neutropenia duration  MAInfo
14 WES analysis of AML samples according to neutropenia duration   TopicSem

2018-04:
07 Lessons learned from additional research analyses of unsolved clinical exome cases     J.Club
17 WES analysis of AML samples according to prolonged neutropenia duration  xMutant

2018-03:
26 Modified workflow and statistical methods for AAP analysis  TopicSem

2018-02:
12 L-asparaginase associated acute pancreatitis in pediatric ALL patients  TopicSem
14 Analysis of AML exome sequencing   xMutant
28 Modified workflow and statistical methods for AAP analysis  MAInfo

2018-01:
04 Data integration patient clinical information with medication history   xMutant
15 Asparaginase-associated pancreatitis in pediatric ALL patients  TopicSem
27 Using ALoFT to determine the impact of putative loss-of-function variants in protein-coding genes     J.Club

2017-12:
13 L-asparaginase associated pancreatitis in pediatric ALL patients   TopicSem

2017-11:
11 Genetic variation in human drug-related genes      J.Club
15 Preprocessing results of 26 AML exome sequencing  MAInfo
20 Analysis of 26 AML exome sequencing  TopicSem
23 Data integration patient sample information with medical record  xMutant

2017-10:
11 Analysis of previously reported variants in pediatric ALL patients  TopicSem

2017-09:
02 Common sequence variants affect molecular function more than rare variants?     J.Club
19 Visualization web application for interaction   MAInfo
26 The comparison the feature of groups in biological network   xMutant

2017-08:
30 Asparaginase-associated pancreatitis in pediatric ALL patients  TopicSem

2017-07:
15 Using large sequencing data sets to refine intragenic disease regions and prioritize clinical variant interpretation     J.Club
24 Asparaginase-associated pancreatitis in pediatric ALL patients  TopicSem
25 Asparaginase-associated pancreatitis in pediatric ALL patients  xMutant
26 Survival analysis of pancreatitis patients using clinical information   MAInfo

2017-06:
07 Asparaginase-associated Pancreatitis in pediatric ALL patients  MAInfo
07 Asparaginase-associated Pancreatitis in pediatric ALL patients   xMutant
21 Asparaginase-associated pancreatitis in pediatric ALL patients  TopicSem

2017-05:
22 WXS to detect genes causing Asparaginase-associated pancreatitis   TopicSem

2017-04:
10 WXS to detect genes causing Asparaginase-associated pancreatitis in 13 SNUH patients  TopicSem
12 a significant variant of NEU4 gene   xMutant
22 SPATIAL: A System-level PAThway Impact AnaLysis approach     J.Club

2017-03:
15 WXS to detect genes causing AAP in 13 SNUH patients   TopicSem
29 WXS to detect genes causing AAP in 13 SNUH patients  MAInfo

2017-02:
01 Clinical information of pancreatitis patients  MAInfo
15 Modification of workflow and statistical methods for AAP analysis  xMutant
18 Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets     J.Club

2017-01:
16 WXS to detect genes causing AAP in 13 SNUH patients  TopicSem

2016-12:
07 WXS to detect genes causing L-asparaginase-associated pancreatitis in ALL patients  TopicSem
07 Patient Information on L-asparaginase associated Pancreatitis  MAInfo
21 Patient Information on L-asparaginase associated Pancreatitis   xMutant
30 Whole-exome sequencing to detect genes causing L-asparaginase-associated pancreatitis in 13 ALL patients  Seminar

2016-11:
02 Whole-exome sequencing to detect genes causing L-asparaginase-associated pancreatitis in 12 ALL patients  TopicSem
12 A pathway-centric approach to rare variant association analysis     J.Club

2016-10:
12 Localization of TCGA clinical data from GDC Data Portal  MAInfo
26 WXS to detect genes causing L-asparaginase induced pancreatitis  xMutant

2016-09:
10 Analysis of protein-coding genetic variation in 60,706 humans     J.Club
19 The human diseases network using genomic information  TopicSem

2016-08:
17 The summary of TCGA clinical data  MAInfo
29 Drug-induced pathways based on CMAP   xMutant

2016-07:
04 Drug-induced pathways based on CMAP  xMutant
27 The analysis for implicating sequence variants in human diseases  TopicSem

2016-06:
04 Network-based in silico drug efficacy screening      J.Club
24 The implications of the biological network for human health  MAInfo
24 The implications of the biological network for human health  MAInfo
27 The complementary interpretations between two pathway groups   TopicSem

2016-05:
06 The summary of TCGA clinical data   MAInfo
09 The review of the human disease using network biology  xMutant
18 Research for investigating genomic characteristics in human disease network  TopicSem

2016-04:
06 Research for investigating characteristics of genome by human disease  TopicSem
09 An Ensemble Based Top Performing Approach for NCI-DREAM Drug Sensitivity Prediction Challenge     J.Club

2016-03:
07 The analysis for association between gene and classified diseases  TopicSem
14 NCI-DREAM drug sensitivity prediction challenge  xMutant
18 Exome-sequence analysis of COAD in TCGA  MAInfo

2016-02:
04 Cancer genome database: COSMIC  MAInfo

2016-01:
16 The interactome of functional variants in human populations  Seminar
19 The interactome of functional variants in 1KP - Gene Score  xMutant
27 The interactome of association between gene and classified diseases  TopicSem
30 Leveraging ancestry to improve causal variant identification in exome sequencing for monogenic disorders     J.Club

2015-12:
01 The review of variant analysis tool, Sequence To Medical Phenotypes  xMutant
16 Characteristics of human genes using ppi information  TopicSem

2015-11:
16 The correlation between function of genes and variants  TopicSem
21 Sequence to Medical Phenotypes: A Framework for Interpretation of Human Whole Genome DNA Sequence Data     J.Club

2015-10:
07 The complementary interpretations between two pathway groups  TopicSem
27 The correlation between function of genes and variants in 1KP  xMutant

2015-09:
15 Relationships of variants through PPI in 1kp data  xMutant

2015-08:
07 The distribution of association with gene and disease according to PPI degree  xMutant
22 Human symptoms-disease network     J.Club
31 The plan of study for rare variants associated to complex disease  TopicSem

2015-07:
15 Results of the properties of biological network using protein interaction  TopicSem

2015-06:
15 The workflow of WXS SG20 analysis  TopicSem

2015-05:
11 The workflow of WXS GS20 analysis  TopicSem
23 Large scale exploration and analysis of drug combinations     J.Club

2015-04:
08 The results of pathway analysis using protein domain   TopicSem

2015-03:
09 The design of simulated network using protein-protein interaction and perturbations  TopicSem
27 Workflow of WGS using GRCh38 reference  xMutant
28 Human Genome Variation and the Concept of Genotype Networks     J.Club

2015-01:
10 The role of the interactome in the maintenance of deleterious variability in human populations     J.Club
21 The comparison of the feature in biological network   TopicSem
26 SG19  Seminar

2014-12:
12 The progress of comparison the feature of two groups in biological network  xMutant
17 The progress of comparison the feature of two groups in biological network  TopicSem

2014-11:
07 The result from WGS data analysis mapped by GRCh38  xMutant
08 Distribution and medical impact of loss-of-function variants in the Finnish founder population     J.Club
12 The introduction to GRCh38/hg38 to analysis WGS data  TopicSem
20 SG19 interpretation  Seminar

2014-10:
16 KEGG Pathway data download using rest API  xMutant

2012-01:
18 Algorithms to prioritize candidate genes underlying diseases  SysBiol
20 A Network-Based Approach to Prioritize Results from Genome-Wide Association Studies      J.Club
25 Interpreting personal genome variations using gene-disease-environment interaction network analysis  SysBiol
31   MAInfo

2011-12:
13 Visualization of gene-disease-environment interaction network analysis  SysBiol
14 Interpreting personal genome variations using gene-disease-environment interaction network  TopicSem
19 Interpreting personal genome variations using gene-disease-environment interaction network   TopicSem
27 The structure of quad-partite graph by gene, disease, environment and DNA methylation   MAInfo
28 Future study for improvement  SysBiol

2011-11:
07 Disease-gene-environment interaction network analysis   TopicSem
08 The structure of disease-etiology database on the epigenomic layer  MAInfo
16 Problems of gene-disease-environment interaction network analysis  SysBiol
23 The construction of disease-gene-environment interaction network  TopicSem
26 Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder     J.Club

2011-10:
05 Work process  SysBiol
10 The analysis of diseases-associated with etiological factors  TopicSem
11 The network of disease-association with etiological factors on the epigenomic layer.  MAInfo
12 PG Seminar preview  SysBiol
13 Etiome annotation  Seminar

2011-09:
02 Gene-environment interaction  SysBiol
06 Epigenetics: A molecular link between environmental factors and disease  MAInfo
07 Etiome annotation  Seminar
14 The relationship of diseases by etiological factors to decipher human genome  TopicSem
21 Gene-environment interaction using 2011 data  SysBiol
24 The implications of relationships between human diseases and metabolic subpathways     J.Club
28 patients statistics  SysBiol

2011-08:
01 The arrangement to extract environmental factors from PubMed articles  TopicSem
05 Factors extraction for etiome replications  SysBiol

2011-07:
04 Relationship between Disease and Etiological factors for deciphering Human genome  SysBiol
13 Design study of disease-etiological factor associations  TopicSem
14 Disease associated-methylation annotator using NGS  MAInfo
30 Obesity related methylation changes in DNA of peripheral blood leukocytes     J.Club

2011-06:
01 Association between disease and etiological factors for personal genome decipher  TopicSem
10 MEDLINE/PubMed Baseline Repository (MBR)  SysBiol
18 Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls     J.Club

2011-05:
11 The expanded research concept for comparison of Metabolic pathways and Non-metabolic pathways  TopicSem
13 Indentity evaluation  SysBiol
17 Introduction of Epigenetics - DNA methylation and analysis tool  MAInfo
27 about etiome  SysBiol
27 systemetic validation result of ADR gene detection  SysBiol

2011-04:
15 Individual topic paper outline  SysBiol
19 simple idea for graduation paper  SysBiol
25 Analysis to show the difference between metabolic and non-metabolic pathways  TopicSem
30 Metabolic Robustness and Network Modularity: A Model Study     J.Club

2011-03:
02 Pathway Analysis by properties of networks   TopicSem
12 A sub-pathway-based approach for identifying drug response principal network     J.Club
23 Data analysis and relation of PPI and DDI among KEGG pathways  TopicSem

2011-02:
09 Protein domain compositions in biological networks  TopicSem

2011-01:
15 Biological Process Linkage Networks     J.Club
17 Domain-Domain interactions in KEGG pathways  TopicSem

2010-12:
07 MagicViewer: integrated solution for next-generation sequencing data visualization and genetic variation detection and annotation     MAInfo
13 AXP Interface Renew  Seminar
27 Protein/ Domain interactions  TopicSem

2010-11:
01 Flow chart for analysis system  Seminar
04 Paper Review for SNP data analysis  SysBiol
13 FMM: a web server for metabolic pathway reconstruction and comparative analysis.     J.Club
24 Pathway analysis of member genes for functional annotation  TopicSem

2010-10:
01 distinct EV_term list  xMutant
01 distinct synonym list     xMutant
04 mapping GEO data with eVOC_terms  Seminar
06 Extension biological network of unknown gene using Protein structure information.  TopicSem
12 Next-generation DNA sequencing     MAInfo
17 ArrayExpress     xMutant
20 for Busan  xMutant
24 empty file list among adf text  xMutant
24 error file list among adf text  xMutant
27 GWAS  SysBiol
29 ArrayExpress adf files  xMutant
31 adf relation  xMutant
31 temp_seminar  SysBiol

2010-09:
07 ArrayExpress down  xMutant
25 Extending pathways based on gene lists using InterPro domain signatures     J.Club

2010-08:
02 Path Finding Approach  Seminar
07 GeneMesh: a web-based microarray analysis tool for relating differentially expressed genes to MeSH terms     J.Club
15 Path Search  SysBiol
19 Study Pathways based on protein structural information.  TopicSem

2010-07:
02 GSEA, GWAS  SysBiol
05 Mapping GEO values on eVOC words  Seminar
05   Seminar
06 赵2  xMutant
19 GEO Query method using eVOC ontology  Seminar
22 Analysis of microarray expression data based on protein structural information  Seminar
22 PANTHER version 6  SysBiol

2010-06:
03 individual project research  SysBiol
04 Compelete GEO data handling  xMutant
10 Paper review process  SysBiol
17 Human Disease-Drug Network  SysBiol
17 evoc data calculating  xMutant
26 PhenoFam-gene set enrichment analysis through protein structural information     J.Club

2010-05:
07 Parsing GDS  xMutant
07 data entries  SysBiol
12 Syntactic integration -KGML, GPML-  Seminar
22 HAMSTER: visualizing microarray experiments as a set of minimum spanning trees     J.Club
27 Syntactic Integration - PID  SysBiol

2010-04:
01 Datamodel of Reactome, PID and INOH  SysBiol
02 Research for GPL, GSM  xMutant
05 Comparison of Pathway Structure and Review of INOH and NCI PID  Seminar
08 Comparison of Ontologies  SysBiol
09   xMutant
15 Comparison of Melecule Role Ontologies  SysBiol
16 GSM attr List  xMutant
17 NeAT: a toolbox for the analysis of biological networks, clusters, classes and pathways     J.Club
22 the Event Ontology & How to extract info using Kegg API  SysBiol
23 GPL attr list  xMutant
30   xMutant

2010-03:
01 KEGG API  SysBiol
04 KGML  SysBiol
06 ConceptGen: a gene set enrichment and gene set relation mapping tool     J.Club
08 the Trends of Statistics Analysis method in major DATABASE  Seminar
11 reactome  SysBiol
18 Reactome model and comparison with NCI PID  SysBiol
19 DATABASE TASK  xMutant
22 Pathway databases Research  Seminar
25 INTERACTION PATHWAY DATABASE  SysBiol
28 DB Ϸ  xMutant

2010-02:
04 Enrichment study with data  SysBiol
09 GEO and How to handle GDS file  xMutant
11 GSEA & MEA  SysBiol
16   xMutant
18 Analysis & KGML  SysBiol
25 Network Analysis  SysBiol

2010-01:
04 trends in biolpgical pathway-based in analysis  Seminar
15 Enrichment Analysis  SysBiol
21 advanced Enrichment Analysis  SysBiol
28 statistics  SysBiol

2009-12:
30 Trends in Biological Pathway-based Analysis  Seminar

powered by SNUBI